Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine gel patch for postherpetic neuralgia
ChiCTR2300068474Phase 3Completed
- Sponsor
- Peking University First Hospital
- Start
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of lidocaine in postherpetic neuralgia (PHN) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Change in average VAS score at week 4. Started Dec 2018; status: completed.
02
Drugs
lidocaine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on ChiCTR2300068474.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068474.